Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01547182 · ClinicalTrials.gov registry record · NA

Cooperative Lifestyle Programs (CLIP-II)

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
249
Enrollment target

NCT01547182: Completed NA study, sponsored by Wake Forest University Health Sciences.

NCT01547182 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 249 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01547182, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
249 participants
Enrollment target

Study Summary

The aim is to study the effects of weight loss and weight loss combined with different types of physical activity on changes in physical functioning of older adults who are at-risk for cardiovascular disease.

Interventions

  • BEHAVIORAL Resistance Training
  • BEHAVIORAL Aerobic Training
  • BEHAVIORAL Caloric restriction

Trial Details

FieldValue
Enrollment Target 249 participants
Start Date 2012-03
Est. Completion 2016-10
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT01547182 record still lists

NCT01547182 is an interventional study that assigns participants to a tested intervention. The registered 249 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 3 interventions - of which Resistance Training is the first listed.

NCT01547182 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01547182 about?

NCT01547182 is a clinical study titled "Cooperative Lifestyle Programs (CLIP-II)". The aim is to study the effects of weight loss and weight loss combined with different types of physical activity on changes in physical functioning of older adults who are at-risk for cardiovascular disease.

What is the current status of trial NCT01547182?

This trial is currently completed. It is a NA study. The enrollment target is 249 participants. The study started on 2012-03. Estimated completion is 2016-10.

What interventions are being tested in trial NCT01547182?

The interventions under investigation include: Resistance Training (BEHAVIORAL), Aerobic Training (BEHAVIORAL), Caloric restriction (BEHAVIORAL).

Who is sponsoring clinical trial NCT01547182?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01547182's enrollment target sits among peer trials

249 434th of 2000 higher than 1,567 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04628767 · 249 participants · Phase 2

    Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

  • NCT05834907 · 249 participants · NA

    Hands and Hearts Together

  • NCT06067555 · 249 participants · Early Phase 1

    Intradermal Influenza Vaccination

  • NCT06588478 · 249 participants · Phase 2

    A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01547182, the US trial registry maintained by the National Library of Medicine. NCT01547182 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.